ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1548

Cutaneous Vasculitis as a Paraneoplastic Syndrome

Javier Loricera1, Vanesa Calvo-Rio2, Francisco Ortiz Sanjuan3, Marcos Antonio Gonzalez-Lopez4, Hector Fernandez-Llaca4, Javier Rueda-Gotor2, Carmen Gonzalez-Vela5, Cristina Mata-Arnaiz3, Miguel A. Gonzalez-Gay2 and Ricardo Blanco2, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, 2Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Dermatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 5Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cutaneous manifestations, malignancy and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Cutaneous Leukocytoclastic Vasculitis (CLV) may be associated with malignancies, and sometimes it behaves as a paraneoplastic syndrome. This association has been reported in a variable proportion of CLV patients (from 0 to 8 %) depending on population selection. Our aim was to assess the frequency and features of CLV associated to neoplasia in a wide and unselected series of CLV.

Methods:

Study of CV associated to neoplasia in a series of 877 patients diagnosed as having CLV in the Rheumatology and Dermatology Divisions from a University Hospital.

Results:

16 out of 877 patients (1.82 %) presenting with CLV were finally diagnosed as having an underlying malignancy. There were 9 hematological and 7 solid malignacies. In all of them, skin lesions were the first clinical manifestation and the median interval to the diagnosis of the malignancy from the onset of CLV was 17 days (range 8 –50 days). The most frequent skin lesions were palpable purpura (13 patients), legs ulcers (2 patients), urticaria (2 patient) and erythema (1 patient). Other manifestations were constitutional syndrome (10 patients) and arthralgias and/ or arthritis (6 cases). There was no serious visceral vasculitic involvement.  Cytopenia was frequently observed in the full blood cell count (11 cases), especially in those cases of vasculitis associated to hematological malignancies. Immature peripheral blood cells were observed in 9 cases. Immunological testing (ANA, Rheumatoid factor, C3, C4, and ANCA) were negative or within normal range in all cases. 10 patients died due to the malignancy and 6 patients recovered following malignancy therapy.

Conclusion:

CLV presenting as a paraneoplastic syndrome is a rare condition. The most common underlying malignancy is generally hematological. The prognosis depends on the underlying neplasia.

 

Case Age/sex Main clinical features Peripheral blood smear Skin biopsy Diagnosis
1 40/F Urticarial lesions, fever, polyarthritis Anemia, immature cells Leukocytoclastic Vasculitis Megakaryocytic leukemia
2 52/F Palpable purpura, constitutional symptoms Pancytopenia, immature cells Leukocytoclastic Vasculitis Myelodysplastic Syndrome
3 56/M Palpable purpura, constitutional symptoms, fever Anemia, leukopenia, immature cells Leukocytoclastic Vasculitis Myelodysplastic Syndrome
4 70/M Palpable purpura, constitutional symptoms, , polyarthritis anemia, leukopenia, immature cells Leukocytoclastic Vasculitis Non- Hodgkin Lymphoma
5 78/M Palpable purpura, constitutional symptoms, fever, arthralgias, abdominal pain Anemia Leukocytoclastic Vasculitis Waldestrom´s Macroglobulinemia
6 83/M Palpable purpura, necrotic ulcer,constitutional symptoms Anemia, leukopenia Leukocytoclastic Vasculitis Myelodysplastic Syndrome
7 61/F Palpable purpura, hematuria,  polyneuopathy Anemia Leukocytoclastic Vasculitis Waldestrom´s Macroglobulinemia
8 76/M Palpable purpura, urticarial lesions, constitutional syptoms, fever Pancytopenia, immature cells Leukocytoclastic Vasculitis Hairy cell leukemia
9 81/F Palpable purpura, erythema, constitutional symptoms, fever Anemia, immature cells Leukocytoclastic Vasculitis Mantle cell lymphoma
10 82/M Palpable purpura,abdominal pain, fecal occult blood,  hematuria Normal Leukocytoclastic Vasculitis Oropharyngeal Squamous cell Carcinoma
11 49/F Palpable purpura, constitutional symptoms, fever Anemia Leukocytoclastic Vasculitis Infiltrating Breast Carcinoma
12 80/M Palpable purpura, constitutional symptoms Anemia Leukocytoclastic Vasculitis Lung Adenocarcinoma
13 85/F Palpable purpura, ulcers Normal Leukocytoclastic Vasculitis Breast Carcinoma
14 53/M Palpable purpura, arthralgias Normal Leukocytoclastic Vasculitis Pyriform sinus squamous cell carcinoma
15 71/M Palpable purpura, constitutional syptoms Normal Leukocytoclastic Vasculitis Bladder carcinoma
16 70/M Palpable purpura Normal Leukocytoclastic Vasculitis Glottic squamous cell carcinoma

Disclosure:

J. Loricera,
None;

V. Calvo-Rio,
None;

F. Ortiz Sanjuan,
None;

M. A. Gonzalez-Lopez,
None;

H. Fernandez-Llaca,
None;

J. Rueda-Gotor,
None;

C. Gonzalez-Vela,
None;

C. Mata-Arnaiz,
None;

M. A. Gonzalez-Gay,
None;

R. Blanco,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cutaneous-vasculitis-as-a-paraneoplastic-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology